Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis

Fig. 7

sFgl2-MSCs increased liver-infiltrating Foxp3-positive cells and reduced RORγ-positive cells and T-bet-positive cells. A Representative infiltration of Foxp3-, RORγ- and T-bet-positive cells in each group. B Data display of Foxp3-positive cells in each group, n = 6. C Data display of RORγ-positive cells in each group, n = 6. D Data display of T-bet-positive cells in each group, n = 6. The black arrows show the positive staining cells. The differences between groups were calculated using ANOVA. ***: P < 0.001. Abbreviations: MSCs, mesenchymal stem cells; sFgl2, soluble fibronectin-like protein 2; WT-MSCs, wild-type MSCs; NC-MSCs, negative control MSCs

Back to article page